Antibody Drug Conjugate News and Research

RSS
Immunotherapy before surgery boosts long term survival in lung cancer, trial shows

Immunotherapy before surgery boosts long term survival in lung cancer, trial shows

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

T-DM1 reduces long-term risk of death in HER2-positive breast cancer patients

T-DM1 reduces long-term risk of death in HER2-positive breast cancer patients

Early detection of breast cancer proven cost-effective for Canada's health care system

Early detection of breast cancer proven cost-effective for Canada's health care system

Chemical compound lights up treatment-resistant cancers on imaging scans

Chemical compound lights up treatment-resistant cancers on imaging scans

New study unveils why glioblastoma becomes resistant to treatment

New study unveils why glioblastoma becomes resistant to treatment

Advances in bladder cancer treatments offer hope for curative care

Advances in bladder cancer treatments offer hope for curative care

New combination treatment authorized for unresectable urothelial cancer patients

New combination treatment authorized for unresectable urothelial cancer patients

New drug could extend the lives of breast cancer patients

New drug could extend the lives of breast cancer patients

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

New cancer drug shows encouraging results in Phase I/II trial

New cancer drug shows encouraging results in Phase I/II trial

New drug shows strong activity against brain metastases in HER2-positive breast cancer

New drug shows strong activity against brain metastases in HER2-positive breast cancer

Telisotuzumab vedotin shows promising results in asian patients with c-Met overexpressing NSCLC

Telisotuzumab vedotin shows promising results in asian patients with c-Met overexpressing NSCLC

A novel therapeutic option for HER2-positive extramammary Paget disease

A novel therapeutic option for HER2-positive extramammary Paget disease

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

Drug shows new promise in treating breast cancer with brain metastases or recurrent glioblastoma

Drug shows new promise in treating breast cancer with brain metastases or recurrent glioblastoma

New treatment option for endometrial cancer shows promise in phase II trial

New treatment option for endometrial cancer shows promise in phase II trial

Antibody-drug conjugate shows preclinical efficacy

Antibody-drug conjugate shows preclinical efficacy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.